Skip to main content
OpenTrials
Completed

NCT Number: NCT00205790

GORE-TEX PROPATEN Vascular Graft Study

To demonstrate equivalence in patency performance of GORE-TEX PROPATEN Vascular Grafts and Thin Walled GORE-TEX Stretch Vascular Grafts in a peripheral bypass application to support a claim of substantial equivalence.

Completed

Looking for future studies?

Notify Me

Key information

Age range

21 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Georgetown University Hospital, Washington D.C., District of Columbia, United States

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient requires primary above-knee bypass where the proximal anastomosis will be to the common femoral or proximal superficial femoral artery and the distal anastomosis will be the popliteal artery proximal to the medial head of the gastrocnemius;
  • Patient has Grade III or IV occlusive vascular disease;
  • Patient has a postoperative life expectancy greater than one year;
  • Patient is at least 21 years of age;
  • Patient is able to comply with all study requirements and be available for follow-up visits at 1 month, 6 months and 12 months post procedure;
  • Patient is willing and able to provide written, informed consent.

Exclusion criteria

  • Patient had a previous bypass in the diseased extremity (below iliacs);
  • Patient has known coagulation disorders including hypercoagulability;
  • Patient has had any previous instance of Heparin Induced Thrombocytopenia type 2 (HIT-2) or has known hypersensitivity to heparin;
  • Patient has an acute embolic arterial occlusion;
  • Patient requires sequential extremity revascularizations or other procedures that require use of additional vascular grafts;
  • Patient had percutaneous transluminal angioplasty to the implant site within the previous 30 days;
  • Patient is in need of, or is scheduled for, a cardiac surgical procedure or a different vascular surgical procedure;
  • Patient has active infection in the region of graft placement; or
  • Patient has an incomplete preoperative assessment (as outlined in this protocol) due to an emergency procedure, a traumatic injury or any other reason.

Treatment and study plan

Vascular graft

Device

Primary outcomes

  1. Primary patency at 12 months

  2. Major device complication rates at 12 months

Secondary outcomes

  1. Technical failures

  2. Secondary patency

Sponsors and collaborators

Lead sponsor

W.L.Gore & Associates

Industry

Registry information

Official study title

Comparison of Primary Patency Between GORE-TEX PROPATEN Vascular Grafts and Thin Walled GORE-TEX Stretch Vascular Grafts

Important dates

Study start
2003
Study completion
2007
First posted
Sep 20, 2005
Registry last updated
Aug 7, 2008

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.